Trial Profile
A Study to Evaluate the Influence of Patient-reported Symptoms on Therapy Decisions in Patients with Incurable Cancer Treated with Sunitinib or Sorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Sunitinib (Primary)
- Indications Cancer
- Focus Adverse reactions
- 23 Dec 2015 New trial record